Researchers analyzed colorectal cancer mortality rates among individuals between 20 and 54 years of age from 1970 through 2014.
Researchers found that a cash incentive of $100 was associated with increased colorectal screening rates in eligible adults.
An increased ADR is associated with an adjusted hazard ratio of 0.63 for interval colorectal cancer and 0.50 for cancer death.
The score could help predict advanced colorectal neoplasia in adults younger than 50 years of age.
A follow-up colonoscopy more than 10 months after a positive FIT result is associated with a higher risk of colorectal cancer and more advanced disease at the time of diagnosis.
Increasing duration of antibiotic use at ages 20 to 39 and 40 to 59 is significantly associated with an increased risk of colorectal adenoma.
The USPSTF has released a recommendation statement regarding screening adults for colorectal cancer.
The USPSTF concluded that a low-dose aspirin regimen can prevent cardiovascular disease and colorectal cancer in adults aged 50 to 59.
A low-dose aspirin regimen was associated with a 3% lower risk of cancer overall.
Nearly 15% of colorectal cancer patients were diagnosed before age 50.
Vitamin D and calcium supplements do not reduce the risk for the development of colorectal adenomas, according to a study published in the New England Journal of Medicine.
A report from WHO found that processed meat causes colorectal cancer, and red meat is positively associated with several cancers.
Adults aged 50 to 75 years should be screened for colorectal cancer. For older adults, the decision to screen should be based on the individual.
Regular, long-term use of low-dose aspirin or other NSAIDs reduced the risk of developing colorectal cancer.
Drinking four or more cups of coffee per day may significantly decrease mortality in colon cancer patients.
Screening colonoscopy leads to higher adenoma detection rates, which reduces colorectal cancer mortality.
The Mississippi Delta region, Appalachia, Virginia, and North Carolina include areas with high rates of colorectal cancer.
The CDC reports that screening rates for colorectal, breast, and cervical cancer have dropped in recent years.
Overweight or obese patients with colorectal cancer had an elevated risk of developing a second cancer compared with normal-weight patients.
Cologuard, a noninvasive home-test, has been approved by the FDA to screen for colorectal cancer.
Postdiagnosis milk intake, but not vitamin D intake, was inversely associated with all-cause mortality.
Nearly 550,000 cases of colorectal cancer have been prevented in United States since 1986.
Fecal immunochemical tests have high diagnostic accuracy and specificity, moderate sensitivity for colorectal cancer, meta-analysis findings show.
Colorectal cancer prevention efforts should encourage the achievement and maintenance of a healthy body weight in addition to regular screenings